Houston, TX, United States of America

Apar Pataer

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Apar Pataer in PKR-Associated Diseases

Introduction

Apar Pataer is an accomplished inventor based in Houston, TX. She has made significant contributions to the field of medical research, particularly in the treatment of diseases associated with RNA-dependent protein kinase (PKR). Her innovative work aims to address critical health challenges, including cancer and neurodegenerative diseases.

Latest Patents

Apar Pataer holds a patent for "Compounds and methods for the treatment of PKR-associated diseases." This patent encompasses RNA-dependent protein kinase (PKR)-associated compounds designed for the treatment of various disorders, including cancer, neurodegenerative diseases, and inflammatory conditions. The patent highlights her commitment to advancing medical science and improving patient outcomes.

Career Highlights

Apar Pataer is affiliated with The University of Texas System, where she continues her research and development efforts. Her work is characterized by a strong focus on innovative solutions to complex medical problems. She has demonstrated a remarkable ability to translate scientific research into practical applications that can benefit society.

Collaborations

Apar collaborates with Bulent Ozpolat, a fellow researcher who shares her passion for advancing medical science. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in research.

Conclusion

Apar Pataer's contributions to the field of PKR-associated diseases reflect her dedication to improving healthcare through innovation. Her work not only highlights her expertise but also underscores the potential for scientific advancements to transform lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…